Overall results by western analysis showed increased Bcl-2, Oct-4 and Sox-2 expression with increased carboplatin concentration which demonstrates that these resistant breast cancer cells have characteristics of cancer stem cell behavior [5–7]. This evidence concerns the gene BCL2 and breast cancer.